Morgan Stanley Institutional Vitality Portfolio (MSVEX)
NASDAQ · Mutual Fund
· Delayed Price · Currency is USD
5.45
-0.01 (-0.18%)
At close: Apr 17, 2025
-8.40% (1Y)
| Fund Assets | 2.29M |
| Expense Ratio | 1.30% |
| Min. Investment | $1,000 |
| Turnover | n/a |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Dividend Growth | n/a |
| Payout Frequency | n/a |
| Ex-Dividend Date | n/a |
| Previous Close | 5.46 |
| YTD Return | -5.71% |
| 1-Year Return | -8.40% |
| 5-Year Return | n/a |
| 52-Week Low | n/a |
| 52-Week High | n/a |
| Beta (5Y) | n/a |
| Holdings | 36 |
| Inception Date | Dec 31, 2021 |
About MSVEX
The Morgan Stanley Institutional Vitality Portfolio (MSVEX) seeks to invest primarily in securities of companies located in the United States that are principally engaged in the discovery, development, production, or distribution of products or services related to advances in healthcare.
Category Health
Stock Exchange NASDAQ
Ticker Symbol MSVEX
Share Class Class A
Index Russell 3000 TR
Performance
MSVEX had a total return of -8.40% in the past year, including dividends. Since the fund's inception, the average annual return has been -4.93%.
Top 10 Holdings
52.41% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company | LLY | 8.13% |
| argenx SE | ARGX | 7.79% |
| Exact Sciences Corporation | EXAS | 6.11% |
| UnitedHealth Group Incorporated | UNH | 5.43% |
| Thermo Fisher Scientific Inc. | TMO | 4.66% |
| Intuitive Surgical, Inc. | ISRG | 4.54% |
| Vertex Pharmaceuticals Incorporated | VRTX | 4.02% |
| Morgan Stanley & Co. LLC - Morgan Stanley Institutional Liquidity Funds - Treasury Securities Portfolio | n/a | 3.96% |
| Alnylam Pharmaceuticals, Inc. | ALNY | 3.90% |
| Align Technology, Inc. | ALGN | 3.87% |